Page last updated: 2024-11-10

5,10-secoestr-5-yne-3,10,17-trione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID3081456
MeSH IDM0083365

Synonyms (8)

Synonym
26012-92-0
5,10-secoestr-4-yne-3,10,17-trione
5,10-secoestr-5-yne-3,10,17-trione
1h-cyclodec(e)indene-3,6,9(2h)-trione, 11,12-didehydro-3a,4,5,5a,7,8,10,13,13a,13b-decahydro-3a-methyl-, (3as-(3ar*,5ar*,13ar*,13br*))-
scoytr
3a-methyl-11,12-didehydro-3a,4,5,5a,7,8,10,13,13a,13b-decahydro-1h-cyclodeca[e]indene-3,6,9(2h)-trione
DTXSID80948911
15-methyltricyclo[8.7.0.011,15]heptadec-7-yne-2,5,14-trione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]